The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Staats, H. F.
Right arrow Articles by Ennis, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Staats, H. F.
Right arrow Articles by Ennis, F. A., Jr.
The Journal of Immunology, 1999, 162: 6141-6147.
Copyright © 1999 by The American Association of Immunologists

IL-1 Is an Effective Adjuvant for Mucosal and Systemic Immune Responses When Coadministered with Protein Immunogens1

Herman F. Staats2 and Francis A. Ennis, Jr.

Departments of Medicine and Immunology, Center for AIDS Research, Duke University Medical Center, Durham, NC 27710

Mucosal immunization with soluble protein Ag alone may induce Ag-specific tolerance, whereas mucosal immunization with Ag in the presence of a mucosal adjuvant may induce Ag-specific systemic and mucosal humoral and cell-mediated immune responses. The most widely used and studied mucosal adjuvant is cholera toxin (CT). Although the mechanism of adjuvanticity of CT is not completely understood, it is known that CT induces mucosal epithelial cells to produce the proinflammatory cytokines IL-1, IL-6, and IL-8 and up-regulates macrophage production of IL-1 and the costimulatory molecule B7.2. Because IL-1 may duplicate many of the activities of CT, we evaluated IL-1{alpha} and IL-1ß for their ability to serve as mucosal adjuvants when intranasally administered with soluble protein Ags. IL-1{alpha} and IL-1ß were as effective as CT for the induction of Ag-specific serum IgG, vaginal IgG and IgA, systemic delayed-type hypersensitivity, and lymphocyte proliferative responses when intranasally administered with soluble protein Ag. Our results indicate that IL-1{alpha} and IL-1ß may be useful as mucosal vaccine adjuvants. Such an adjuvant may be useful, and possibly required, for vaccine-mediated protection against pathogens that infect via the mucosal surfaces of the host such as HIV.




This article has been cited by other articles:


Home page
 Hum Exp ToxicolHome page
M Baranska, L Van Amelsvoort, S Birindelli, S Fustinoni, E Corsini, J Liesivuori, and H Van Loveren
Association of pesticide exposure, vaccination response, and interleukin-1 gene polymorphisms
Human and Experimental Toxicology, September 1, 2008; 27(9): 709 - 713.
[Abstract] [PDF]

Home page
 Protein Eng Des SelHome page
S. Lata and G.P.S. Raghava
CytoPred: a server for prediction and classification of cytokines
Protein Eng. Des. Sel., April 1, 2008; 21(4): 279 - 282.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C.-F. Flach, F. Qadri, T. R. Bhuiyan, N. H. Alam, E. Jennische, I. Lonnroth, and J. Holmgren
Broad Up-Regulation of Innate Defense Factors during Acute Cholera
Infect. Immun., May 1, 2007; 75(5): 2343 - 2350.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Duverger, R. J. Jackson, F. W. van Ginkel, R. Fischer, A. Tafaro, S. H. Leppla, K. Fujihashi, H. Kiyono, J. R. McGhee, and P. N. Boyaka
Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens
J. Immunol., February 1, 2006; 176(3): 1776 - 1783.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Kobayashi, T. Kohda, K. Kataoka, H. Ihara, S. Kozaki, D. W. Pascual, H. F. Staats, H. Kiyono, J. R. McGhee, and K. Fujihashi
A Novel Neurotoxoid Vaccine Prevents Mucosal Botulism
J. Immunol., February 15, 2005; 174(4): 2190 - 2195.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. W. Peacock, S. K. Nordone, S. S. Jackson, H.-X. Liao, N. L. Letvin, A. G. Yafal, L. Gritz, G. P. Mazzara, B. F. Haynes, and H. F. Staats
Gender Differences in Human Immunodeficiency Virus Type 1-Specific CD8 Responses in the Reproductive Tract and Colon following Nasal Peptide Priming and Modified Vaccinia Virus Ankara Boosting
J. Virol., December 1, 2004; 78(23): 13163 - 13172.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. Hajishengallis, H. Nawar, R. I. Tapping, M. W. Russell, and T. D. Connell
The Type II Heat-Labile Enterotoxins LT-IIa and LT-IIb and Their Respective B Pentamers Differentially Induce and Regulate Cytokine Production in Human Monocytic Cells
Infect. Immun., November 1, 2004; 72(11): 6351 - 6358.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. M. Eriksson, K. M. Schon, and N. Y. Lycke
The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues
J. Immunol., September 1, 2004; 173(5): 3310 - 3319.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. M. Gherardi, E. Perez-Jimenez, J. L. Najera, and M. Esteban
Induction of HIV Immunity in the Genital Tract After Intranasal Delivery of a MVA Vector: Enhanced Immunogenicity After DNA Prime-Modified Vaccinia Virus Ankara Boost Immunization Schedule
J. Immunol., May 15, 2004; 172(10): 6209 - 6220.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. Eriksson, M. Fredriksson, I. Nordstrom, and J. Holmgren
Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development
Infect. Immun., April 1, 2003; 71(4): 1740 - 1747.
[Abstract] [Full Text]

Home page
 Mol Hum ReprodHome page
S. Cauci, S. Guaschino, D. de Aloysio, S. Driussi, D. De Santo, P. Penacchioni, and F. Quadrifoglio
Interrelationships of interleukin-8 with interleukin-1{beta} and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women
Mol. Hum. Reprod., January 1, 2003; 9(1): 53 - 58.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. P. Bradney, G. D. Sempowski, H.-X. Liao, B. F. Haynes, and H. F. Staats
Cytokines as Adjuvants for the Induction of Anti-Human Immunodeficiency Virus Peptide Immunoglobulin G (IgG) and IgA Antibodies in Serum and Mucosal Secretions after Nasal Immunization
J. Virol., January 15, 2002; 76(2): 517 - 524.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. F. Staats, C. P. Bradney, W. M. Gwinn, S. S. Jackson, G. D. Sempowski, H.-X. Liao, N. L. Letvin, and B. F. Haynes
Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization
J. Immunol., November 1, 2001; 167(9): 5386 - 5394.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. N. Shi, H. Y. Liu, and C. Nagler-Anderson
Enteric Infection Acts as an Adjuvant for the Response to a Model Food Antigen
J. Immunol., December 1, 2000; 165(11): 6174 - 6182.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. S. Wild, A. Sigounas, N. Sur, M. S. Siddiqui, R. Alam, M. Kurimoto, and S. Sur
IFN-{gamma}-Inducing Factor (IL-18) Increases Allergic Sensitization, Serum IgE, Th2 Cytokines, and Airway Eosinophilia in a Mouse Model of Allergic Asthma
J. Immunol., March 1, 2000; 164(5): 2701 - 2710.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Williamson, G. M. Westrich, and J. L. Viney
Modulating Dendritic Cells to Optimize Mucosal Immunization Protocols
J. Immunol., October 1, 1999; 163(7): 3668 - 3675.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.